The budget-friendly Australian wine brand is updating its look in moment of decline for the wine industry. Yellow Tail, the budget-friendly Australian wine brand known to college students everywhere, ...

Samuel S Chowdhury, chairman of Square Pharmaceuticals, yesterday expressed his willingness to purchase 15 lakh shares of the company, valued at over Tk 32 crore at the current market price.

Swiss pharmaceutical company Novartis is staying put at its Midtown office right next to Bryant Park. “We worked closely with Novartis to secure a new lease extension that addressed the firm’s current ...

Sun Pharma, India's largest pharmaceutical company, is set to acquire Checkpoint Therapeutics for $355 million. This strategic acquisition will enhance Sun Pharma's specialty portfolio ...

Warren, Wyden, and Sanders wrote to Kennedy that “the dinners may have served as an opportunity for Big Pharma to gain insider access to both you and President Trump” and asked the HHS chief to reveal ...

As of September 30, 2024, the company had 4.7 million dollars in cash, with accounts payable and accrued expenses totaling 17.6 million dollars. This acquisition follows Sun Pharma’s 576 million ...

In a report released today, Marc Frahm from TD Cowen maintained a Buy rating on Inozyme Pharma (INZY – Research Report). The company’s shares opened today at $1.14. Effectively assess a stock ...

And it's the type of research that big pharmaceutical companies might not find potentially profitable enough to invest in. "A lot of the grants I'm talking about are in cancer, for pediatric ...

OKYO Pharma (OKYO) announces the filing of its application for Fast Track designation, FTD, with the U.S. Food and Drug Administration, FDA, for urcosimod for the treatment of neuropathic corneal ...

A growing number of prominent companies have scaled back or set aside the diversity, equity and inclusion initiatives that much of corporate America endorsed following the protests that ...

Senores Pharmaceuticals Ltd on Thursday said it has secured nearly Rs 261 crore from anchor investors. The Rs 582-crore IPO will conclude on December 24. The IPO has a price range of Rs 372-391 per ...